BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 5, 2003
View Archived Issues
Completion of phase I study of vaccinia immune globulin
Read More
Screening commences for phase II study of Prosaptide
Read More
Advanced Biotherapy to study antibody therapy in organ transplant rejection
Read More
Roche presents novel DPP-IV inhibitors in a recent patent
Read More
New HIV protease inhibitors prepared and tested at Tibotec-Virco
Read More
Lundbeck claims glycine transport inhibitors and their use in psychosis, cognition disorders, etc.
Read More
Novel PDE7 inhibitors and their use reported by Daiichi Suntory and Suntory scientists
Read More
HNE inhibitors with potential in COPD therapy covered by Bayer patent
Read More
Bayer researchers design adenosine A1 receptor agonists for ischemic disorders
Read More
New mGluR1 antagonists in early development at Bayer
Read More
Two series of adenosine A3 receptor antagonists described by Sanofi-Synthelabo
Read More
Analgesic effects reported for KRN-5500 in a murine model of neuropathic pain
Read More
Potential use of interferon in the therapy of SARS
Read More
Priority review for diquafosol tetrasodium NDA
Read More
Bexxar launched in U.S.
Read More
Small-molecule Bcl-2 inhibitor with apoptosis-inducing effects in cancer cells
Read More
Cytogen completes reacquisition of Quadramet marketing rights
Read More
Evotec Neurosciences and Takeda form Alzheimer's collaboration
Read More
Maxim discusses discovery and development of apoptosis inducers at cancer meeting
Read More
Enbrel approved to improve physical function in RA patients
Read More
FDA approves Zavesca for type 1 Gaucher's disease
Read More
Japan Tobacco to commercialize Gilead HIV products in Japan
Read More
FDA advisory committee sets review date for Raptiva
Read More